Ocugen (OCGN) Cash & Equivalents Growth (5y) (2019 - 2025)
Ocugen (OCGN) Cash & Equivalents Growth (5y) (2019 - 2025) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
| 10 |
Ocugen |
411.07 Mn |
411.07 Mn |
- |
| Date | Value |
|---|
| Mar 31, 2025 |
63.93% |
| Jun 30, 2024 |
87.44% |
| Mar 31, 2024 |
143.45% |
| Dec 31, 2023 |
89.19% |
| Sep 30, 2023 |
84.76% |
| Jun 30, 2023 |
51.74% |
| Mar 31, 2023 |
34.50% |
| Dec 31, 2022 |
61.40% |
| Sep 30, 2022 |
56.57% |
| Jun 30, 2022 |
61.21% |
| Mar 31, 2022 |
51.29% |
| Dec 31, 2021 |
24.37% |
| Sep 30, 2021 |
23.09% |
| Jun 30, 2021 |
48.66% |
| Mar 31, 2021 |
14.36% |
| Dec 31, 2020 |
-4.91% |
| Sep 30, 2020 |
-12.72% |
| Jun 30, 2020 |
-19.84% |
| Mar 31, 2020 |
-43.02% |
| Dec 31, 2019 |
-33.80% |
